{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:14:39Z","timestamp":1790705679341,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,2,22]],"date-time":"2014-02-22T00:00:00Z","timestamp":1393027200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10620-014-3079-5","type":"journal-article","created":{"date-parts":[[2014,2,21]],"date-time":"2014-02-21T05:04:08Z","timestamp":1392959048000},"page":"881-885","source":"Crossref","is-referenced-by-count":2,"title":["Plasma Triglyceride Levels May Modulate Hepatitis C Viral Replication"],"prefix":"10.1007","volume":"59","author":[{"given":"David H.","family":"Van Thiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar M.","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Ramadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niculae","family":"Ion-Nedelcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,22]]},"reference":[{"key":"3079_CR1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/gut.2004.050302","volume":"54","author":"L Fartoux","year":"2005","unstructured":"Fartoux L, Poujol-Robert A, Guechot J, et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut. 2005;54:1003\u20131008.","journal-title":"Gut."},{"key":"3079_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.25628","volume":"56","author":"C Scholtes","year":"2012","unstructured":"Scholtes C, Rami\u00e8re C, Rainteau D, et al. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients. Hepatology.. 2012;56:39\u201348.","journal-title":"Hepatology."},{"key":"3079_CR3","doi-asserted-by":"crossref","first-page":"e17309","DOI":"10.1371\/journal.pone.0017309","volume":"6","author":"M Nishimura","year":"2011","unstructured":"Nishimura M, Yamamoto H, Yoshida T, et al. Decreases in the serum VLDL-TG\/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels. PLoS One. 2011;6:e17309.","journal-title":"PLoS One."},{"key":"3079_CR4","first-page":"898","volume":"54","author":"M Irshad","year":"2007","unstructured":"Irshad M, Dhar I, Gupta S, et al. Correlation of serum HCV core concentration with blood level of lipid and antioxidants in various forms of liver diseases. Hepatogastroenterology. 2007;54:898\u2013902.","journal-title":"Hepatogastroenterology."},{"key":"3079_CR5","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ajg.2008.125","volume":"104","author":"CS Hsu","year":"2009","unstructured":"Hsu CS, Liu CH, Liu CJ, et al. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection. Am J Gastroenterol. 2009;104:598\u2013604.","journal-title":"Am J Gastroenterol."},{"key":"3079_CR6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/s-2005-864785","volume":"25","author":"P Andr\u00e9","year":"2005","unstructured":"Andr\u00e9 P, Perlemuter G, Budkowska A, et al. Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis. 2005;25:93\u2013104.","journal-title":"Semin Liver Dis."},{"key":"3079_CR7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2003.11.020","volume":"126","author":"A Lonardo","year":"2004","unstructured":"Lonardo A, Adinolfi LE, Loria P, et al. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology. 2004;126:586\u2013597.","journal-title":"Gastroenterology."},{"key":"3079_CR8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/jhep.2002.35064","volume":"36","author":"A Monto","year":"2002","unstructured":"Monto A, Alonzo J, Watson JJ, et al. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology. 2002;36:729\u2013736.","journal-title":"Hepatology."},{"key":"3079_CR9","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1111\/j.1365-2893.2011.01439.x","volume":"18","author":"S Petta","year":"2011","unstructured":"Petta S, Di Marco V, Di Stefano R, et al. TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1. J Viral Hepat. 2011;18:e372\u2013e380.","journal-title":"J Viral Hepat."},{"key":"3079_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1096\/fj.01-0396com","volume":"16","author":"G Perlemuter","year":"2002","unstructured":"Perlemuter G, Sabile A, Letteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. Faseb J.. 2002;16:185\u2013194.","journal-title":"Faseb J."},{"key":"3079_CR11","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/hep.510300429","volume":"30","author":"A Sabile","year":"1999","unstructured":"Sabile A, Perlemuter G, Bono F, et al. Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology. 1999;30:1064\u20131076.","journal-title":"Hepatology."},{"key":"3079_CR12","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1007\/s10620-006-9719-7","volume":"52","author":"JM Petit","year":"2007","unstructured":"Petit JM, Jooste V, Duvillard L, et al. Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C. Dig Dis Sci. 2007;52:3431\u20133434.","journal-title":"Dig Dis Sci."},{"key":"3079_CR13","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1053\/j.gastro.2010.07.047","volume":"139","author":"DJ Felmlee","year":"2010","unstructured":"Felmlee DJ, Sheridan DA, Bridge SH, et al. Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. Gastroenterology. 2010;139:1774\u20131783.","journal-title":"Gastroenterology."},{"key":"3079_CR14","doi-asserted-by":"crossref","first-page":"33466","DOI":"10.1074\/jbc.M109.019810","volume":"284","author":"H Lerat","year":"2009","unstructured":"Lerat H, Kammoun HL, Hainault I, et al. Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice. J Biol Chem. 2009;284:33466\u201333474.","journal-title":"J Biol Chem."},{"key":"3079_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.21016","volume":"43","author":"Y Nahmias","year":"2006","unstructured":"Nahmias Y, Casali M, Barbe L, et al. Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles in primary rat and human hepatocytes. Hepatology. 2006;43:257\u2013265.","journal-title":"Hepatology."},{"key":"3079_CR16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00281-012-0356-2","volume":"35","author":"MF Bassendine","year":"2013","unstructured":"Bassendine MF, Sheridan DA, Bridge SH, et al. Lipids and HCV. Semin Immunopathol.. 2013;35:87\u2013100.","journal-title":"Semin Immunopathol."},{"key":"3079_CR17","doi-asserted-by":"crossref","unstructured":"Sun HY, Lin CC, Lee JC, et al. Very low-density lipoprotein\/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Gut. 2012; doi: 10.1136\/gutjnl-2011-301798 .","DOI":"10.1136\/gutjnl-2011-301798"},{"key":"3079_CR18","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","volume":"76","author":"P Andr\u00e9","year":"2002","unstructured":"Andr\u00e9 P, Komurian-Pradel F, Deforges S, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol. 2002;76:6919\u20136928.","journal-title":"J Virol."},{"key":"3079_CR19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jacl.2013.06.004","volume":"7","author":"JA Rizzo","year":"2013","unstructured":"Rizzo JA, Mallow PJ, Waters HC. Managing to low-density lipoprotein particles compared with low-density lipoprotein cholesterol: a cost-effectiveness analysis. J Clin Lipidol. 2013;7:642\u2013652.","journal-title":"J Clin Lipidol."},{"key":"3079_CR20","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2036.2009.04012.x","volume":"29","author":"DA Sheridan","year":"2009","unstructured":"Sheridan DA, Price DA, Schmid ML, et al. Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin. Aliment Pharmacol Ther. 2009;29:1282\u20131290.","journal-title":"Aliment Pharmacol Ther."},{"key":"3079_CR21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000282105","volume":"28","author":"F Negro","year":"2010","unstructured":"Negro F. Hepatitis C virus-induced steatosis: an overview. Dig Dis.. 2010;28:294\u2013299.","journal-title":"Dig Dis."},{"key":"3079_CR22","doi-asserted-by":"crossref","unstructured":"Chen L, Liu W, Lai S, et al. Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients. Eur J Gastroenterol Hepatol. 2013 (Epub ahead of print).","DOI":"10.1097\/MEG.0b013e32835fa988"},{"key":"3079_CR23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/00952990.2011.563335","volume":"37","author":"ZJ Pereska","year":"2011","unstructured":"Pereska ZJ, Bozinovska C, Dimitrovski C, et al. Plasma apo\/lipoproteins disturbances as a precondition for metabolic syndrome in HCV seronegative heroin addicts. Am J Drug Alcohol Abuse. 2011;37:196\u2013202.","journal-title":"Am J Drug Alcohol Abuse."},{"key":"3079_CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/hep.23796","volume":"52","author":"D Ramcharran","year":"2010","unstructured":"Ramcharran D, Wahed AS, Conjeevaram HS, et al. Associations between serum lipids and hepatitis C antiviral treatment efficacy. Hepatology. 2010;52:854\u2013863.","journal-title":"Hepatology."},{"key":"3079_CR25","doi-asserted-by":"crossref","unstructured":"Albecka A, Belouzard S, Op de Beeck A, et al. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology. 2012;55 998\u20131007.","DOI":"10.1002\/hep.25501"},{"key":"3079_CR26","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/gut.2010.222133","volume":"60","author":"SH Bridge","year":"2011","unstructured":"Bridge SH, Sheridan DA, Felmlee DJ, et al. Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection. Gut. 2011;60:680\u2013687.","journal-title":"Gut."},{"key":"3079_CR27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.2010.211292","volume":"60","author":"C Mancone","year":"2011","unstructured":"Mancone C, Steindler C, Santangelo L, et al. Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins. Gut. 2011;60:378\u2013386.","journal-title":"Gut."},{"key":"3079_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MOL.0b013e3282feea85","volume":"19","author":"MM Hussain","year":"2008","unstructured":"Hussain MM, Rava P, Pan X, et al. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr Opin Lipidol. 2008;19:277\u2013284.","journal-title":"Curr Opin Lipidol."},{"key":"3079_CR29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2893.2011.01553.x","volume":"19","author":"PJ Clark","year":"2012","unstructured":"Clark PJ, Thompson AJ, Zhu M, et al. Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response. J Viral Hepat. 2012;19:332\u2013340.","journal-title":"J Viral Hepat."},{"key":"3079_CR30","doi-asserted-by":"crossref","unstructured":"Shinohara Y, Imajo K, Yoneda M, et al. Hepatic triglyceride lipase plays an essential role in changing the lipid metabolism in genotype 1b hepatitis C virus replicon cells and hepatitis C patients. Hepatol Res. 2013. doi: 10.1111\/hepr.12072 .","DOI":"10.1111\/hepr.12072"},{"key":"3079_CR31","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/jmv.23345","volume":"84","author":"MC Roque-Cu\u00e9llar","year":"2012","unstructured":"Roque-Cu\u00e9llar MC, S\u00e1nchez B, Garc\u00eda-Lozano JR, et al. Expression of CD81, SR-BI and LDLR in lymphocytes and monocytes from patients with classic and occult hepatitis C virus infection. J Med Virol.2012;84:1727\u20131736.","journal-title":"J Med Virol."},{"key":"3079_CR32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1665-2681(19)31462-0","volume":"11","author":"MA Khattab","year":"2012","unstructured":"Khattab MA, Eslam M, Mousa YI, et al. Association between metabolic abnormalities and hepatitis C-related hepatocellular carcinoma. Ann Hepatol. 2012;11:487\u2013494.","journal-title":"Ann Hepatol."},{"key":"3079_CR33","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1099\/vir.0.82033-0","volume":"87","author":"O Diaz","year":"2006","unstructured":"Diaz O, Delers F, Maynard M, et al. Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins. J Gen Virol. 2006;87:2983\u20132991.","journal-title":"J Gen Virol."},{"key":"3079_CR34","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.3748\/wjg.v11.i38.5944","volume":"11","author":"P Toniutto","year":"2005","unstructured":"Toniutto P, Fabris C, Avellini C, et al. Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation. World J Gastroenterol. 2005;11:5944\u20135945.","journal-title":"World J Gastroenterol."},{"key":"3079_CR35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/hep.23787","volume":"52","author":"SA Harrison","year":"2010","unstructured":"Harrison SA, Rossaro L, Hu KQ, et al. Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy. Hepatology. 2010;52:864\u2013874.","journal-title":"Hepatology."},{"key":"3079_CR36","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.3748\/wjg.15.5020","volume":"15","author":"KA Forde","year":"2009","unstructured":"Forde KA, Law C, O\u2019Flynn R, et al. Do statins reduce hepatitis C RNA titers during routine clinical use? World J Gastroenterol. 2009;15:5020\u20135027.","journal-title":"World J Gastroenterol."},{"key":"3079_CR37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.biochi.2012.07.016","volume":"95","author":"J Blaising","year":"2013","unstructured":"Blaising J, P\u00e9cheur EI. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies. Biochimie. 2013;95:96\u2013102.","journal-title":"Biochimie."},{"key":"3079_CR38","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1200\/JCO.2012.44.6831","volume":"31","author":"YT Tsan","year":"2013","unstructured":"Tsan YT, Lee CH, Ho WC, et al. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol. 2013;31:1514\u20131521.","journal-title":"J Clin Oncol."},{"key":"3079_CR39","doi-asserted-by":"crossref","first-page":"317580","DOI":"10.1155\/2012\/317580","volume":"2012","author":"N Taura","year":"2012","unstructured":"Taura N, Ichikawa T, Miyaaki H, et al. Baseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2. Gastroenterol Res Pract. 2012;2012:317580. Epub Nov 5 2012.","journal-title":"Gastroenterol Res Pract."},{"key":"3079_CR40","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s10620-009-1125-5","volume":"55","author":"MF Madhoun","year":"2010","unstructured":"Madhoun MF, Bader T. Statins improve ALT values in chronic hepatitis C patients with abnormal values. Dig Dis Sci. 2010;55:870\u2013871.","journal-title":"Dig Dis Sci."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3079-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-014-3079-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-014-3079-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T16:55:39Z","timestamp":1565196939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-014-3079-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,22]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["3079"],"URL":"https:\/\/doi.org\/10.1007\/s10620-014-3079-5","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,22]]}}}